Genmab — Juli 2024

[E_L]

ESMO 2024 preview – conjugates in the spotlight https://www.oncologypipeline.com/apexonco/node/734 rinatabart

[Hen]

Medicinalselskabet Genmab har fået skruet på kursmålet af amerikanske Goldman Sachs. Investeringsbanken øger målet til 2378 kr. fra 2242 kr., mens anbefalingen fastholdes som "neutral". Marketwire.

[E_L]

Epcoritamab vs SoC (SCHOLAR-5 cohort) in patients with R/R FL https://www.youtube.com/watch?v=SQgjUgIJU4E

[E_L]

Tisotumab Vedotin Continues to Show Survival Benefits in Recurrent Cervical Cancer https://www.targetedonc.com/view/tisotumab-vedotin-continues-to-show-survival-benefits-in-recurrent-cervical-cancer

[Helge_LarsenPI-redaktør]

Thanks E L.

[E_L]

from the Morningstart report on Novartis: several other drugs continue to post rapid gains. In particular, multiple
sclerosis drug Kesimpta (up 65%) holds the potential to exceed management's peak annual sales
guidance of $4 billion based on leading efficacy and convenient dosing

[E_L]

Topo-1 and FRα: Key Focus Areas and Major Collaborations in ADC Research – Part I https://www.geneonline.com/topo-1-and-frα-key-focus-areas-and-major-collaborations-in-adc-research-part-i/

[E_L]

Genmab i teknisk udbrud op gennem 50 dages MA, plus 12 % på tre uger https://ugebrev.dk/flashnews/genmab-i-teknisk-udbrud-op-gennem-50-dages-ma-plus-12-paa-tre-uger/

[Solsen]

MA200 ligger omkring 2024 kr jf Yahoo. Det ville være dejligt med en konsolidering over dette niveau Men selvfølgelig tilfreds MA50 til en start.

[Raun]

Et spørgsmål til teknikerne..... Hvornår gør et gap luk sig gældende?.... Tænker at nu har vi set Genmab forhåbentlig have lavet en vending/bund i omkring kurs 1700.... Nu da aktien jo egentlig ikke har dannet en bund i dette niveau, siger teknikken så at vi skal have lukket det gap, førend en eventuel optur kan fortsætte?

[Solsen]

Gap er spring i kursniveauerne fra dag til dag. Men jo nogen gange er der dobbeltbund eller -top, hvilket er noget andet.

[Solsen]

Men der er sikkert en der har syr på det

[Solsen]

..styr…

[E_L]

some gaps close, some remain open forever. Some 'runaway gaps' can actually run away from the gap very fast. So I don't trade them as such. The open and close points of the gap can often be seen as resistance or support though, i think that is much more tradeable.

[E_L]

AbbVie's EPKINLY Receives First-Ever Time-Limited Reimbursement Recommendation by Canada's Drug Agency https://finance.yahoo.com/news/abbvies-epkinly-receives-first-ever-110200465.html

[Raun]

Mange tak for svar E L

[E_L]

Hemab Therapeutics
@Hemab_Tx
“The whole system stops working.”

This is the story of Glanzmann thrombasthenia. The transfusion of platelets – which seems like an obvious solution – is sometimes simply not an option. https://x.com/Hemab_Tx/status/1815718038802444611

[Solsen]

Siden bunden er der et gap mellem den 11. og 12. Juli på 50 øre. Det blev lukket den 15. Juli. Så rent bord til fortsatte stigninger, hvis man er TA-troende https://finance.yahoo.com/quote/GMAB.CO/chart/#eyJpbnRlcnZhbCI6ImRheSIsInBlcmlvZGljaXR5IjoxLCJjYW5kbGVXaWR0aCI6Ni40MjczNTA0MjczNTA0MjgsInZvbHVtZVVuZGVybGF5Ijp0cnVlLCJjcm9zc2hhaXIiOnRydWUsImNoYXJ0VHlwZSI6ImNhbmRsZSIsImV4dGVuZGVkIjpmYWxzZSwibWFya2V0U2Vzc2lvbnMiOnt9LCJhZ2dyZWdhdGlvblR5cGUiOiJvaGxjIiwiY2hhcnRTY2FsZSI6ImxpbmVhciIsInBhbmVscyI6

[Raun]

Tak Solsen

[Solsen]

Et firma vi måske skal holde øje med https://www.linkedin.com/posts/peter-lebowitz_solidtumors-inflammatory-immunology-activity-7221493419771129856-AXPG?utm_source=share&utm_medium=member_ios